Burden of illness of chemotherapy in castration-resistant prostate cancer patients in Japan: a retrospective database analysis-Reference-Cited by-同舟云学术

Burden of illness of chemotherapy in castration-resistant prostate cancer patients in Japan: a retrospective database analysis

Published:2018-05-09 Issue:10 Volume:34 Page:1855-1860
ISSN:0300-7995
Container-title:Current Medical Research and Opinion
language:en
Short-container-title:Current Medical Research and Opinion

Author:

Mahlich Joerg¹²^ORCID,Tsubota Akiko¹,Imanaka Keiichiro³,Enjo Kentaro⁴

Affiliation:

1. Janssen Pharma Kabushiki Kaisha, Health Economics, Chiyoda-ku, Japan;

2. Heinrich-Heine-Universitat Dusseldorf Wirtschaftswissenschaftliche Fakultat, Dusseldorf, Germany;

3. Janssen Japan – Oncology Development Dept. Clinical Science Division, Chiyoda-ku, Japan;

4. Janssen Pharma Kabushiki Kaisha, Prostate Cancer Group, Chiyoda-ku, Japan

Funder

Janssen Pharmaceutical KK

Publisher

Informa UK Limited

Subject

General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/03007995.2018.1462782

Reference39 articles.

1. National Cancer Center. Cancer statistics 2016. Available at: http://ganjoho.jp/reg_stat/statistics/stat/summary.html [Last accessed 27 April 2017]

2. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012

3. Cost of illness of the prostate cancer in Japan—a time-trend analysis and future projections

4. National Cancer Center. Cancer incident rate 2017. Available at: http://ganjoho.jp/reg_stat/statistics/stat/summary.html [Last accessed 27 April 2017]

5. Docetaxel plus Prednisone or Mitoxantrone plus Prednisone for Advanced Prostate Cancer

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Central Nervous System-related Conditions and Associated Healthcare Resource Use Among Japanese nmCRPC Patients Based on Retrospective Claims Data;Journal of Health Economics and Outcomes Research;2023-10-31

2. Central Nervous System-related Conditions and Associated Healthcare Resource Use Among Japanese nmCRPC Patients Based on Retrospective Claims Data;Journal of Health Economics and Outcomes Research;2023-10-31

3. A pharmacoeconomic evaluation of pharmaceutical treatment options for prostate cancer;Expert Opinion on Pharmacotherapy;2021-06-02

4. Die Bedeutung von Big Data für klinische Entwicklungen und den Marktzugang;Digitale Transformation von Dienstleistungen im Gesundheitswesen VII;2020

5. A population-based study of the humanistic burden among cancer patients in Japan;Journal of Medical Economics;2019-12-31